200 related articles for article (PubMed ID: 22824956)
1. Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells.
Lim SC; Duong HQ; Parajuli KR; Han SI
Oncol Rep; 2012 Oct; 28(4):1429-34. PubMed ID: 22824956
[TBL] [Abstract][Full Text] [Related]
2. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid effectively kills drug-resistant gastric cancer cells through induction of autophagic death.
Lim SC; Han SI
Oncol Rep; 2015 Sep; 34(3):1261-8. PubMed ID: 26133914
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition.
Lee J; Hong EM; Kim JH; Kim JH; Jung JH; Park SW; Koh DH; Jang HJ
Mol Biol Rep; 2021 Sep; 48(9):6231-6240. PubMed ID: 34392440
[TBL] [Abstract][Full Text] [Related]
5. Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
Bui HTT; Le NH; Le QA; Kim SE; Lee S; Kang D
Int J Med Sci; 2019; 16(11):1412-1423. PubMed ID: 31673231
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases.
Pang L; Zhao X; Liu W; Deng J; Tan X; Qiu L
Nutrients; 2015 May; 7(5):3200-18. PubMed ID: 25951128
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells.
Im E; Martinez JD
J Nutr; 2004 Feb; 134(2):483-6. PubMed ID: 14747693
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MEK sensitizes gastric cancer cells to TRAIL-induced apoptosis.
Wu P; Cheng YW; Wang JY; Zhang XD; Zhang LJ
Neoplasma; 2014; 61(2):136-43. PubMed ID: 24299309
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells.
Oh YT; Deng J; Yue P; Sun SY
Sci Rep; 2016 May; 6():26803. PubMed ID: 27222248
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
12. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
13. Involvement of ERK1/2-mediated ELK1/CHOP/DR5 pathway in 6-(methylsulfinyl)hexyl isothiocyanate-induced apoptosis of colorectal cancer cells.
Yano S; Wu S; Sakao K; Hou DX
Biosci Biotechnol Biochem; 2019 May; 83(5):960-969. PubMed ID: 30730256
[TBL] [Abstract][Full Text] [Related]
14. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
Guenther MK; Graab U; Fulda S
Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
[TBL] [Abstract][Full Text] [Related]
15. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5.
Kim EY; Yu JS; Yang M; Kim AK
Mol Cells; 2013 Jan; 35(1):32-40. PubMed ID: 23224239
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
17. Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells.
Abdel-Latif MM; Inoue H; Reynolds JV
Eur J Cancer Prev; 2016 Sep; 25(5):368-79. PubMed ID: 26378497
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase M1 interacts with A-Raf and inhibits endoplasmic reticulum stress-induced apoptosis by activating MEK1/ERK pathway in mouse insulinoma cells.
Horiuchi Y; Nakatsu D; Kano F; Murata M
Cell Signal; 2017 Oct; 38():212-222. PubMed ID: 28743549
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing.
Oh YT; Deng J; Yue P; Owonikoko TK; Khuri FR; Sun SY
Oncogene; 2016 Jan; 35(4):459-67. PubMed ID: 25867065
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.
Li L; Wen XZ; Bu ZD; Cheng XJ; Xing XF; Wang XH; Zhang LH; Guo T; Du H; Hu Y; Fan B; Ji JF
Oncol Rep; 2016 May; 35(5):3009-17. PubMed ID: 26986870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]